118 S133 RS: NAPA Reauthorization Act
U.S. Senate
2023-07-27
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
II
Calendar No. 182
118th CONGRESS
1st Session
S. 133
IN THE SENATE OF THE UNITED STATES
January 30, 2023
Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, Mr. Moran, Mr. Menendez, Ms. Murkowski, Ms. Stabenow, Mr. Lankford, Mr. Wicker, Mr. Crapo, Mr. Warnock, Mr. Scott of Florida, Mr. Boozman, Mr. Daines, Mr. Bennet, Mr. Rubio, Ms. Rosen, Mrs. Gillibrand, Mr. Cramer, Mrs. Hyde-Smith, Mr. Tillis, Ms. Smith, Mr. Hickenlooper, Mr. Van Hollen, Mrs. Fischer, and Mr. Budd) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
July 27, 2023
Reported by Mr. Sanders, with an amendment
Strike out all after the enacting clause and insert the part printed in italic
A BILL
To extend the National Alzheimer's Project.
1.

Short title
This Act may be cited as the “NAPA Reauthorization Act”.
2.

Extension of project
Section 2 of the National Alzheimer's Project Act (42 U.S.C. 11225) is amended—
(1)
in subsection (c)—
(A)
in paragraph (2), by striking “and coordination of” and inserting “on, and coordination of,”;
(B)
in paragraph (4)—
(i)
by redesignating subparagraphs (A) and (B) as subparagraphs (B) and (C), respectively; and
(ii)
by inserting before subparagraph (B), as so redesignated, the following:
“(A)
promotion of healthy aging and reduction of risk factors for Alzheimer's;”;
(C)
in paragraph (5), by striking “; and” and inserting a semicolon;
(D)
by redesignating paragraph (6) as paragraph (7); and
(E)
by inserting after paragraph (5) the following:
“(6)
provide information on, and promote the adoption of, healthy behaviors that may reduce the risk of cognitive decline and promote and protect cognitive health; and”;
(2)
in subsection (d)(2)—
(A)
by inserting “, across public and private sectors,” after “Nation's progress”; and
(B)
by inserting “, including consideration of public-private collaborations, as appropriate” before the period;
(3)
in subsection (e)—
(A)
in paragraph (2)—
(i)
in subparagraph (A), by adding at the end the following:
“(xi)
A designee of the Department of Justice.
(xii)
A designee of the Federal Emergency Management Agency.
(xiii)
A designee of the Social Security Administration.
(xiv)
A designee of the Office of Management and Budget.
(xv)
1 or more other designees of the Department of Health and Human Services, as determined by the Secretary of Health and Human Services.”; and
(ii)
in subparagraph (B)—
(I)
in clause (v)—
- (aa)
by striking “2 researchers” and inserting “3 researchers”; and
- (bb)
by striking “; and” and inserting “, including at least one researcher with demonstrated experience in recruitment and retention of diverse cohorts of trial participants;”;
(II)
in clause (vi), by striking the period and inserting “; and”; and
(III)
by adding at the end the following:
“(vii)
an individual with a diagnosis of Alzheimer's disease.”;
(B)
in paragraph (5)—
(i)
in subparagraph (A)—
(I)
by striking “an initial evaluation” and inserting “annual evaluations”; and
(II)
by striking “research, clinical” and inserting “research, risk reduction, public health, clinical”;
(ii)
in subparagraph (B), by striking “initial”;
(iii)
in subparagraph (C)—
(I)
in the matter preceding clause (i), by striking “initial”; and
(II)
in clause (ii), by inserting “and reduce disparities” before the semicolon; and
(iv)
in subparagraph (D), by striking “annually thereafter, an evaluation” and inserting “annual evaluations”; and
(C)
in paragraph (6), by striking “2025” and inserting “2035”;
(4)
in subsection (g)(3)(A)(ii), by inserting “and reduce disparities” before the semicolon; and
(5)
in subsection (h), by striking “2025” and inserting “2035”.
1.

Short title
This Act may be cited as the “NAPA Reauthorization Act”.
2.

Extension of project
Section 2 of the National Alzheimer's Project Act (42 U.S.C. 11225) is amended—
(1)
in subsection (c)—
(A)
in paragraph (2), by striking “and coordination of” and inserting “on, and coordination of,”;
(B)
in paragraph (4)—
(i)
by redesignating subparagraphs (A) and (B) as subparagraphs (B) and (C), respectively; and
(ii)
by inserting before subparagraph (B), as so redesignated, the following:
“(A)
promotion of healthy aging and reduction and mitigation of risk factors for Alzheimer's;”;
(C)
in paragraph (5)—
(i)
by inserting “and other underserved populations, including individuals with developmental disabilities such as Down syndrome,” after “ethnic and racial populations”; and
(ii)
by striking “; and” and inserting a semicolon;
(D)
by redesignating paragraph (6) as paragraph (7); and
(E)
by inserting after paragraph (5) the following:
“(6)
provide information on, and promote the adoption of, healthy behaviors that may reduce the risk of cognitive decline and promote and protect cognitive health; and”;
(2)
in subsection (d)(2)—
(A)
by inserting “, across public and private sectors,” after “Nation's progress”; and
(B)
by inserting “, including consideration of public-private collaborations, as appropriate” before the period;
(3)
in subsection (e)—
(A)
in paragraph (2)—
(i)
in subparagraph (A), by adding at the end the following:
“(xi)
A designee of the Department of Justice.
(xii)
A designee of the Federal Emergency Management Agency.
(xiii)
A designee of the Social Security Administration.
(xiv)
2 or more other designees, as determined by the Secretary of Health and Human Services, at least one of whom has expertise in risk factors associated with the development or the progression of Alzheimer's.”; and
(ii)
in subparagraph (B)—
(I)
in the matter preceding clause (i), by striking “12” and inserting “15”;
(II)
in clause (v)—
- (aa)
by striking “2 researchers” and inserting “3 researchers”; and
- (bb)
by striking “; and” and inserting “, including at least one researcher with demonstrated experience in recruitment and retention of diverse cohorts of trial participants;”;
(III)
in clause (vi), by striking the period and inserting a semicolon; and
(IV)
by adding at the end the following:
“(vii)
1 individual with a diagnosis of Alzheimer's disease; and
(viii)
1 representative from a historically underserved population whose lifetime risk for developing Alzheimer's is markedly higher than that of other populations.”;
(B)
in paragraph (5)—
(i)
in subparagraph (A)—
(I)
by striking “an initial evaluation” and inserting “annual evaluations”; and
(II)
by striking “research, clinical” and inserting “research, risk reduction, public health, clinical”;
(ii)
in subparagraph (B), by striking “initial”;
(iii)
in subparagraph (C)—
(I)
in the matter preceding clause (i), by striking “initial”; and
(II)
in clause (ii), by inserting “and reduce disparities” before the semicolon; and
(iv)
in subparagraph (D), by striking “annually thereafter, an evaluation” and inserting “annual evaluations”; and
(C)
in paragraph (6), by striking “2025” and inserting “2035”;
(4)
in subsection (g)(3)(A)(ii), by inserting “and reduce disparities” before the semicolon; and
(5)
in subsection (h), by striking “2025” and inserting “2035”.
July 27, 2023
Reported with an amendment